Results 11 to 20 of about 36,549 (313)
Frontiers in Immunology, 2022 Obesity and its associated Metabolic Syndromes (Mets) represent a global epidemic health problem. Metabolic inflammation, lipid accumulation and insulin resistance contribute to the progression of these diseases, thereby becoming targets for drug ...
Mengyu Dai +5 more
doaj +1 more source
Frontiers in Endocrinology, 2022 BackgroundOsteoporosis is a multifactorial disorder and a number of genetic variants or loci responsible for bone mineral density (BMD) have been identified.
Sundus Tariq +5 more
doaj +1 more source
BIOCHEMICAL PATHWAYS OF METABOLIC DISORDERS IN PSORIASIS
Juvenis Scientia, 2021 The development of metabolic disorders occurs in psoriasis: insulin resistance, systemic inflammation, atherosclerosis, oxidative stress and obesity. The paper presents pathological biochemical pathways of metabolic disorders development which is caused ...
O. V. Samburskaya +2 more
doaj +1 more source
Exercise in the cold causes greater irisin release but may not be enough for adropin
Chinese Journal of Physiology, 2021 When irisin and adropin were discovered, it was popularly hoped that they would become therapies for metabolic disorders that threaten global health. However, contradictory results have been reported in the subsequent period.
Suleyman Ulupinar +5 more
doaj +1 more source
, 2022 INTRODUCTION: Adipokines may play a role in the early stages of rheumatoid arthritis. This study evaluated the performance of adipokines in a Colombian population with early rheumatoid arthritis and its relationship with disease activity.
Bello-Gualtero, Juan Manuel +11 more
core +1 more source
Biomolecules, 2021 Aberrant circulating omentin-1, which is an anti-inflammatory and pro-apoptotic adipokine, has been reported in various solid tumors. Therefore, we investigated whether or not circulating omentin-1 could be associated with postmenopausal BC (PBC) and ...
Gerasimos Socrates Christodoulatos +11 more
doaj +1 more source
Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin [PDF]
, 2009 OBJECTIVE - Lipocalin-2, a novel adipokine, has been shown to be elevated in obese, insulin-resistant, and diabetic Subjects. We therefore sought to study the ex vivo and in vivo effects of insulin on lipocalin-2 levels in humans. RESEARCH DESIGN AND
Randeva, Harpal S. +6 more
core +1 more source
Clinical and Experimental Pharmacology and Physiology, 2011 Summary1. Obesity is a major risk factor for cardiovascular disease. An increased body mass index (BMI) is associated with venous thromboembolism, myocardial infarction, stroke and stent thrombosis after percutaneous interventions. Studies in mouse models of obesity and induced arterial or venous thrombosis have provided insights into the mechanisms ...
Schaefer, Katrin +1 more
openaire +3 more sources
Low serum cartonectin/CTRP3 concentrations in newly diagnosed Type 2 Diabetes Mellitus : in vivo regulation of Cartonectin by glucose [PDF]
, 2014 Objectives: Cartonectin is a novel adipokine of the C1q complement/TNF-related protein (CTRP) superfamily, with glucose lowering effects, anti-inflammatory and cardio-protective properties. We sought to investigate circulating cartonectin concentrations
Jing Chen +22 more
core +1 more source
Obesity as a risk factor for multiple myeloma: insight on the role of adipokines
Pathology and Oncology Research, 2023 Multiple myeloma (MM) is a hematologic disorder characterized by the accumulation of malignant plasma cells in the bone marrow. Genetic and environmental factors are contributed to the etiology of MM.
Wenting Tie +8 more
doaj +1 more source